← Back to headlines
Bombay High Court Criticizes Drug Regulator Over Cipla License Cancellation
The Bombay High Court has reprimanded India's drug regulatory authority for its handling of the license cancellation case involving pharmaceutical company Cipla.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Turkey Mediates New Black Sea Grain Deal Amid Disrupted Shipping Routes
21m ago
Ghana Supreme Court Dismisses Injunction Against SkyTrain Trial
31m ago
Carney Appoints Dominic Barton to Chair Invest in Canada Agency
54m ago
Supreme Court Allows Construction to Continue on Trump’s White House Ballroom
1h ago